Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04051983Completed

iVision - Development of a Game-based Therapy for Children With Cerebral Visual Impairment

Role: collaborator

NCT05276037Recruiting

Value of Negative 18FDG PET/CT in Milan Out, Up-to-seven in, HCC Transplant Candidates

Role: collaborator

NCT03669913Not ApplicableUnknown

Mitigating Adverse Sexual and Reproductive Health Outcomes Among Young Adolescents

Role: collaborator

NCT03423927Not ApplicableCompleted

Benefits of an Intervention Combining Hypnosis and Self-care for Prostate Cancer Patients

Role: collaborator

NCT02290457Not ApplicableCompleted

Core Strength Training in Youth

Role: collaborator

All 5 trials loaded